At a glance
The January 25, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on clinical laboratory result abnormalities with COVID-19, SARS-CoV-2 variants, CMS billing, and an FDA update.
Agenda
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
What Are the Clinical Laboratory Result Abnormalities in Patients Hospitalized with COVID-19?: Nadia Ayala-Lopez, Johns Hopkins Medical Institute
COVID-19 Variants and Surveillance: Chris Elkins, CDC COVID-19 Laboratory and Testing Task Force
CMS Billing Update: Sarah Harding, Centers for Medicare & Medicaid Services (CMS)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)